Articles Tagged With: COVID-19
-
Black Elderberry Supplementation for Upper Respiratory Infection Symptoms
SYNOPSIS: A meta-analysis of results from four randomized, controlled clinical studies evaluating the effect of black elderberry supplementation suggests that the botanical significantly reduces upper respiratory symptoms due to common cold and influenza viruses.
-
Shortcuts in Clinical Trials May Cause More Harm Than Good
Dozens of potential treatments for COVID-19 are under investigation: existing antiretrovirals, anti-malaria drugs, monoclonal antibodies, and Chinese traditional medicines among them. Additionally, companies are rapidly developing new drugs. But poorly designed studies subject patients to the risks of adverse events without learning if the intervention works.
-
Second Phase of Pandemic Raises More Questions, Concerns for IRBs
Research organizations and IRBs continue to face challenges and make tough decisions based on the best available information about a pandemic that changes daily as it spreads across the world.
-
What Happens to Human Research in the New Pandemic Era?
The big question in the clinical research world is how things will look when the COVID-19 pandemic has ended. Will everything go back to the way it was? If not, what changes will remain?
-
Federal Agencies, Pharma Industry Work to Speed COVID-19 Therapeutics, Vaccine
Public-private partnership aims to streamline, coordinate large-scale efforts.
-
The Role of Surgeons in the COVID-19 Era
Accrediting body helps surgery leaders find the right path forward during unusual times.
-
COVID-19 and Children
In China, children of all ages have been infected with SARS-CoV-2 and seem to follow a relatively mild clinical course.
-
COVID-19: What Providers Should Know
The disease associated with COVID-19 is now a significant event in world history, with uncertain but likely major consequences for individuals, families, healthcare workers, health systems, and the global economy. There remains a great deal to learn.
-
Implications of COVID-19 for Primary Care
Primary care physicians often are the first to communicate with potential COVID-19 patients. Without definitive testing, it is challenging to reliably provide an accurate differential diagnosis, but there is a developing list of signs and symptoms associated with COVID-19.
-
EMTALA 1135 Waivers Allow Flexibility
The Centers for Medicare & Medicaid Services issued waivers for some Emergency Medical Treatment & Labor Act (EMTALA) requirements, acknowledging certain expectations are not reasonable to achieve during a pandemic. However, EMTALA still applies.